DEVELOPMENT HISTORY
1994---Brand Veterinary Medicine Retail Chain
2002---Establish Wuhan HVSEN Biotechnology Co., ltd
2007---Establish Wuhan Xinhuaxing Animal Health Chain Service Co., Ltd
2009---Acquisition of Spn Animal Pharmaceutical
2009---Establish Hubei HVSEN Biotechnology Co., ltd
2015---Comprehensive preparations and important production lines were put into operation
2017--- Hubei HVSEN Biotechnology Co., ltd. Expand Production
2018---Building Intelligent Plant
2020--- The 1000 tons of Tylosin tartrate project was put into operation
2020---Listed in the public company in Aug.2020
HVSEN is focusing on the innovation of novel macrolides APIs and preparations, with 42 patents and 3 certificated novel APIs. It has been famous of tylvalosin raw material, various tylvalosin preparations, florfenicol preparations and other macrolides products in the market. Presently HVSEN has the capability of producing more than 50 veterinary drug products of raw materials & preparations, also some traditional Chinese medicines (TCMs) extractives.
